Literature DB >> 16433755

Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.

L A Lexis1, A Fenning, L Brown, R G Fassett, J S Coombes.   

Abstract

The aim of this study was to determine the effects of dietary antioxidant supplementation with alpha-tocopherol and alpha-lipoic acid on cyclosporine-induced alterations to erythrocyte and plasma redox balance, and cyclosporine-induced endothelial and smooth muscle dysfunction. Rats were randomly assigned to either control, antioxidant, cyclosporine or cyclosporine + antioxidant treatments. Cyclosporine A was administered for 10 days after an 8-week feeding period. Plasma was analyzed for alpha-tocopherol, total antioxidant capacity, malondialdehyde and creatinine. Erythrocytes were analyzed for glutathione, methemoglobin, superoxide dismutase, catalase, glutathione peroxidase, glucose-6-phosphate dehydrogenase, alpha-tocopherol and malondialdehye. Vascular endothelial and smooth muscle function was determined in vitro. Antioxidant supplementation resulted in significant increases in erythrocyte alpha-tocopherol concentration and glutathione peroxidase activity in both of the antioxidant-supplemented groups. Cyclosporine administration caused significant decreases in glutathione concentration, methemoglobin concentration and superoxide dismutase activity. Antioxidant supplementation attenuated the cyclosporine-induced decrease in superoxide dismutase activity. Cyclosporine therapy impaired both endothelium-independent and -dependent relaxation of the thoracic aorta, and this was attenuated by antioxidant supplementation. In summary, dietary supplementation with alpha-tocopherol and alpha-lipoic acid attenuated the cyclosporine-induced decrease in erythrocyte superoxide dismutase activity and attenuated cyclosporine-induced vascular dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16433755     DOI: 10.1111/j.1600-6143.2005.01154.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  7 in total

1.  Cardioprotective and hepatoprotective effects of ellagitannins from European oak bark (Quercus petraea L.) extract in rats.

Authors:  Sunil K Panchal; Lindsay Brown
Journal:  Eur J Nutr       Date:  2011-11-22       Impact factor: 5.614

Review 2.  Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions.

Authors:  Uwe Christians; Jost Klawitter; Jelena Klawitter; Nina Brunner; Volker Schmitz
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-02       Impact factor: 4.481

3.  Lipoic acid significantly restores, in rats, the age-related decline in vasomotion.

Authors:  A R Smith; F Visioli; B Frei; T M Hagen
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

4.  Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.

Authors:  Masahiko Yano; Masanori Ikeda; Ken-Ichi Abe; Hiromichi Dansako; Shogo Ohkoshi; Yutaka Aoyagi; Nobuyuki Kato
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

5.  A Regenerative Antioxidant Protocol of Vitamin E and α-Lipoic Acid Ameliorates Cardiovascular and Metabolic Changes in Fructose-Fed Rats.

Authors:  Jatin Patel; Nur Azim Matnor; Abishek Iyer; Lindsay Brown
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

6.  Erythrocyte antioxidant protection of rose hips (Rosa spp.).

Authors:  C Widén; A Ekholm; M D Coleman; S Renvert; K Rumpunen
Journal:  Oxid Med Cell Longev       Date:  2012-07-08       Impact factor: 6.543

7.  Astaxanthin vs placebo on arterial stiffness, oxidative stress and inflammation in renal transplant patients (Xanthin): a randomised controlled trial.

Authors:  Robert G Fassett; Helen Healy; Ritza Driver; Iain K Robertson; Dominic P Geraghty; James E Sharman; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-12-18       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.